“…For instance, human C/D box snoRNAs specifically expressed in the brain have been implicated in the interference with A-to-I editing (Vitali et al, 2005) and in the regulation of alternative mRNA splicing of the serotonin receptor (Kishore and Stamm, 2006). The human non-coding growth arrestspecific transcript 5 (GAS5), which encodes ten different snoRNAs in its introns (U44, U47, U74, U75, U76, U77, U78, U79, U80, U81; Smith and Steitz, 1998), was shown to play a critical role in the control of cell growth and apoptosis, to be down regulated in breast cancer (Mourtada-Maarabouni et al, 2009), and has evoked as a candidate gene in the development of autoimmune disease (Mourtada- Maarabouni et al, 2008). Together with the recent demonstration of tumor suppressor characteristics in the human snoRNA U50 (Dong et al, 2008), these observations suggest that snoRNA genes may be involved in controlling oncogenesis and sensitivity to therapy in cancer.…”